Making Medicines in Africa: The Political Economy of Industrializing for Local Health (International Political Economy Series)

This book is open access under a CC-BY license. The importance of the pharmaceutical industry in Sub-Saharan Africa, its claim to policy priority, is rooted in the vast unmet health needs of the sub-continent. Making Medicines in Africa is a collective endeavour, by a group of contributors with a strong African and more broadly Southern presence, to find ways to link technological development, investment and industrial growth in pharmaceuticals to improve access to essential good quality medicines, as part of moving towards universal access to competent health care in Africa. The authors aim to shift the emphasis in international debate and initiatives towards sustained Africa-based and African-led initiatives to tackle this huge challenge. Without the technological, industrial, intellectual, organisational and research-related capabilities associated with competent pharmaceutical production, and without policies that pull the industrial sectors towards serving local health needs, the African sub-continent cannot generate the resources to tackle its populations' needs and demands. Research for this book has been selected as one of the 20 best examples of the impact of UK research on development. See http://www.ukcds.org.uk/the-global-impact-of-uk-research for further details. Front Matter....Pages i-xxi Introduction: African Industrial Development, Values and Health Care....Pages 1-4 Front Matter....Pages 5-6 Making Medicines in Africa: An Historical Political Economy Overview....Pages 7-24 Pharmaceuticals in Kenya: The Evolution of Technological Capabilities....Pages 25-44 Pharmaceutical Manufacturing Decline in Tanzania: How Possible Is a Turnaround to Growth?....Pages 45-64 Bringing Industrial and Health Policies Closer: Reviving Pharmaceutical Production in Ethiopia....Pages 65-84 South-South Collaboration in Pharmaceuticals: Manufacturing Anti-retroviral Medicines in Mozambique....Pages 85-102 Can Foreign Firms Promote Local Production of Pharmaceuticals in Africa?....Pages 103-121 Raising the Technological Level: The Scope for API, Excipients, and Biologicals Manufacture in Africa....Pages 122-143 Front Matter....Pages 145-145 Health Systems as Industrial Policy: Building Collaborative Capabilities in the Tanzanian and Kenyan Health Sectors and Their Local Suppliers....Pages 147-165 The Dissemination of Local Health Innovations: Political Economy Issues in Brazil....Pages 166-182 Healthy Industries and Unhealthy Populations: Lessons from Indian Problem-Solving....Pages 183-199 Front Matter....Pages 201-202 Policies to Control Prices of Medicines: Does the South African Experience Have Lessons for Other African Countries?....Pages 203-223 Pharmaceutical Standards in Africa: The Road to Improvement and Their Role in Technological Capability Upgrading....Pages 224-242 Innovative Procurement for Health and Industrial Development....Pages 243-260 Industry Associations and the Changing Politics of Making Medicines in South Africa....Pages 261-277 Finance and Incentives to Support the Development of National Pharmaceutical Industries....Pages 278-297 Back Matter....Pages 298-334 "The importance of the pharmaceutical industry in Sub-Saharan Africa, its claim to policy priority, is rooted in the vast unmet health needs of the sub-continent. Making Medicines in Africa is a collective endeavour, by a group of contributors with a strong African and more broadly Southern presence, to find ways to link technological development, investment and industrial growth in pharmaceuticals to improve access to essential good quality medicines, as part of moving towards universal access to competent health care in Africa. The authors aim to shift the emphasis in international debate and initiatives towards sustained Africa-based and African-led initiatives to tackle this huge challenge. Without the technological, industrial, intellectual, organisational and research-related capabilities associated with competent pharmaceutical production, and without policies that pull the industrial sectors towards serving local health needs, the African sub-continent cannot generate the resources to tackle its populations'' needs and demands."--Publisher's description This book is open access under a CC-BY license. This book is about medicines production in sub-Saharan Africa, an enquiry driven by the vast unmet health needs of the sub-continent. It is a collective endeavour by a group of editors and authors with a strong African and more broadly Southern presence to find ways forward that link technological development, investment and industrial growth in pharmaceuticals to improve access to essential good quality medicines, as part of moving towards universal access to competent health care. We aim to shift the emphasis in international debate to give much more attention to the scope for sustained Africa-based and African-led initiatives to tackle this huge challenge. Without the technological, industrial, intellectual, organisational and research-related capabilities associated with competent pharmaceutical production, and without policies that pull the industrial sectors towards serving local health needs, the African sub-continent cannot generate the resources to tackle the needs and demands of its population "This is a book about pharmaceutical production in sub-Saharan Africa, an enquiry driven by the vast unmet health needs of the sub-continent. It is a collective endeavour by a group of editors and authors with a strong African and more broadly Southern presence to find ways forward that link technological development, investment and industrial growth in pharmaceuticals to improve access to essential good quality medicines, as part of moving towards universal access to competent health care. We aim to shift the emphasis in international debate to give much more attention to the scope for sustained Africa-based and African-led initiatives to tackle this huge challenge. Without the technological, industrial, intellectual, organisational and research-related capabilities associated with competent pharmaceutical production, and without policies that pull the industrial sectors towards serving local health needs, the African sub-continent cannot generate the resources to tackle the needs and demands of its population"--Back cover This open access book deals with imaging of the abdomen and pelvis, an area that has seen considerable advances over the past several years, driven by clinical as well as technological developments. The respective chapters, written by internationally respected experts in their fields, focus on imaging diagnosis and interventional therapies in abdominal and pelvic disease; they cover all relevant imaging modalities, including magnetic resonance imaging, computed tomography, and positron emission tomography. As such, the book offers a comprehensive review of the state of the art in imaging of the abdomen and pelvis. It will be of interest to general radiologists, radiology residents, interventional radiologists, and clinicians from other specialties who want to update their knowledge in this area

Gastrointestinal disease; PET/CT; Radiology; X-ray; IDKD; Davos